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everal determinants of aging, including metabolic
capacity and genetic stability, are recognized in both
yeast and humans. However, many aspects of the
pathways leading to cell death remain to be elucidated.
Here we report a role for the actin cytoskeleton both in cell
death and in promoting longevity. We have analyzed yeast
strains expressing mutants with either increased or decreased
actin dynamics. We show that decreased actin dynamics
causes depolarization of the mitochondrial membrane and
an increase in reactive oxygen species (ROS) production,
S
 
resulting in cell death. Important, however, is the demon-
stration that increasing actin dynamics, either by a speciﬁc
actin allele or by deletion of a gene encoding the actin-
bundling protein Scp1p, can increase lifespan by over
65%. Increased longevity appears to be due to these cells
producing lower than wild-type levels of ROS. Homology
between Scp1p and mammalian SM22/transgelin, which
itself has been isolated in senescence screens, suggests a
conserved mechanism linking aging to actin stability.
 
Introduction
 
Aging is the progressive decline in the ability of an organism
to resist stress, damage, and disease. However, variation
within populations means that manifestations of age-related
decline or functional senescence can be hard to distinguish
from maturational events or disease. Yeast has been used as a
model organism for studies of cell aging for several years.
The ability to rapidly exploit genomic information has led to
the identification of several markers that are important in
the progression of aging. Furthermore, it seems that a small
number of physiological principles underlie the aging pro-
cess. These include metabolic capacity, resistance to stress,
gene dysregulation, and genetic stability. These factors have
also been identified as critical in aging in other organisms,
including humans.
Coupled to the process of aging is the presence of tightly
regulated mechanisms, which ensure that aged cells undergo
cell death. Such pathways are critical in multicellular organ-
isms to allow maintenance of tissues and organ structure.
However, it is clear that apoptotic pathways that culminate
in cell death also occur in single cell organisms. One possible
reason for this in yeast is that old cells are less robust and
their presence may become deleterious to the well being of a
colony. The presence of apoptotic pathways in yeast that
resemble those in higher organisms has been well dem-
onstrated (Frohlich and Madeo, 2001; Tissenbaum and
Guarente, 2002). As observed in mammalian cells, apoptotic
yeast cells show mitochondrial depolarization, high levels of
reactive oxygen species (ROS), DNA fragmentation, and
phosphoserine exposure at the plasma membrane. There is
also good evidence that these apoptotic pathways are part of
the normal aging process (Laun et al., 2001; Jazwinski,
2002). The role of the caspase-like protein Yca1p in yeast is
less well understood, though there is evidence that caspase-
dependent cell death pathways are present and contribute to
the process of programmed cell death (Madeo et al., 2002).
 
However, even 
 
 
 
yca1
 
 cells show rapid death in elevated
H
 
2
 
O
 
2
 
 levels, demonstrating the presence of other mechanisms
to induce cell death.
Several recent studies have reported induction of apoptosis
in mammalian cells associated with changes in the actin
cytoskeleton (Kim et al., 2003; Morley et al., 2003). To
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further our understanding of this phenomenon, we have un-
dertaken studies in the budding yeast 
 
Saccharomyces cerevi-
siae
 
. Previous studies in yeast have generated much informa-
tion on fundamental roles of the actin cytoskeleton because
this organism expresses a single form of actin and there is
ready availability of mutant actin alleles. Here we demon-
strate that a decrease in actin dynamics can induce cell death
through the production of ROS from the mitochondria.
Conversely, increasing actin dynamics reduces production of
ROS and increases cell viability. Finally, we determine that
deletion of a single gene, encoding the actin bundling pro-
tein Scp1, leads to a reduced production of ROS and a
highly significant increase in longevity.
 
Results and discussion
 
Investigations into the loss in viability of certain actin mu-
tants led to the observation that a reduction in actin dynam-
ics correlates with an inability to grow on the nonfermentable
carbon source glycerol. Actin alleles 
 
act1
 
-
 
157
 
 (increased actin
dynamics) and 
 
act1
 
-
 
159
 
 (decreased actin dynamics) and an
isogenic parent strain (Belmont and Drubin, 1998; Belmont
et al., 1999) were compared for growth on agar plates con-
taining either 2% glucose, the preferred 
 
S.
 
 
 
cerevisiae
 
 carbon
source, or 3% glycerol. As shown (Fig. 1 a), strains expressing
the 
 
act1
 
-
 
159
 
 allele are unable to grow using glycerol as a car-
bon source. Growth on glycerol requires functional mito-
chondria (Hampsey, 1997). The presence of mitochondria in
these cells was determined using a GFP tag fused to a mito-
chondrial targeting sequence (Westermann and Neupert,
2000), and mitochondrial function was assessed using the vi-
tal stain DiOC
 
6
 
, which requires a membrane potential to be
taken up and retained within mitochondria. Interestingly,
while in early log phase, all three strains contain mitochon-
dria with a relatively normal morphology, the mitochondria
in the 
 
act1
 
-
 
159
 
 strain could not be visualized using the
DiOC
 
6
 
 dye, indicating that the mitochondria have a signifi-
cantly reduced membrane potential (Fig. 1 b).
It is well documented in yeast and higher eukaryotes that
loss of mitochondrial membrane potential can lead to in-
creased production of ROS, which can then lead to induc-
tion of apoptotic-like changes and consequently to cell death
(Madeo et al., 1999; Laun et al., 2001). Indeed, there is
much evidence in yeast that accumulation of ROS is a major
factor in aging (Longo et al., 1996; Nestelbacher et al.,
2000). To assess whether these changes also occur in the ac-
tin mutant strains, FACS
 
®
 
 analysis was undertaken to mea-
sure H
 
2
 
O
 
2
 
 levels as an indication of ROS accumulation. As
shown (Fig. 1 c), this analysis reveals two populations of
cells. The M2 population represents those cells with a high
level of ROS accumulation. While the 
 
act1
 
-
 
159
 
 mutant has
significantly increased ROS levels compared with wild-type
cells, the 
 
act1
 
-
 
157
 
 mutant has reduced ROS levels. To dem-
onstrate that mitochondria are required for the observed in-
crease in ROS, strains of the 
 
act1
 
-
 
159
 
 mutant were gener-
ated that lacked mitochondrial DNA (Guthrie and Fink
1991). These yeast strains (designated rho
 
 
 
) did not show
the increase in ROS production observed in the parent
strain, indicating the importance of the mitochondria for
the ROS production observed (Fig. 1 d).
 
An important consideration is whether the changes to ac-
tin are caused by, or are a consequence of, elevated ROS. Ac-
tin staining of the 
 
act1
 
-
 
159
 
 strain revealed some disorganiza-
tion of the actin cytoskeleton with fewer, larger chunks of
cortical actin and aberrant actin cables (Fig. 1 e). This phe-
notype was not rescued in the rho
 
 
 
 strain that has lower lev-
els of ROS, demonstrating that actin disorganization occurs
upstream of the production of ROS from the mitochondria.
We also observed that the actin phenotype was exacerbated
as 
 
act1
 
-
 
159
 
 cells entered stationary phase and that it cor-
related with an increased incidence of DNA fragmenta-
tion (unpublished data). To determine whether this actin
“chunk” phenotype correlated with the ROS production, we
also investigated actin organization of wild-type and 
 
act1
 
-
 
157
 
 cells after 28 d in stationary phase. Here we found a
clear difference between the strains, with 45% of wild-type
cells containing large actin chunks compared with only 16%
of 
 
act1
 
-
 
157
 
 cells (Fig. 1 f), demonstrating a role for actin dy-
namics within stationary phase cells.
To ascertain whether the changes in ROS levels correlated
with longevity, we compared viability of the yeast strains
over a period of 28 d after entry into stationary phase. This
approach allows assessment of chronological lifespan of
yeast, which mimics aging of post-mitotic tissues in higher
organisms (MacLean et al., 2001). The strain with reduced
actin dynamics had all died by 10 d. After 28 d, wild-type
cells showed 38.5% (
 
 
 
2.1%) viability, and the strain with
increased dynamics showed 51% (
 
 
 
3.3%) viability, an in-
crease of 32%, suggesting a link between actin dynamics,
ROS production, and longevity. To demonstrate that the
ROS responsible for cell death are derived from mitochon-
drial activity, viability of the 
 
act1
 
-
 
159 
 
strain and 
 
act1
 
-
 
159
 
rho
 
 
 
 strain were compared. This measurement was per-
formed on log phase cells because the lack of mitochon-
dria precludes the rho
 
 
 
 strains from entering stationary
phase. Under these conditions, viability of 
 
act1
 
-
 
159
 
 cells was
50.1% (
 
 
 
5.8), and viability of the 
 
act1
 
-
 
159
 
 rho
 
 
 
 cells was
93.7% (
 
 
 
2.2), demonstrating the importance of mitochon-
dria in production of ROS, which results in cell death.
To determine whether the cell death induced by ROS in
response to the actin mutation is due to caspase activation,
we incubated yeast with FITC-labeled VAD-fmk. This
molecule binds specifically to the catalytic site of metazoan
caspases and has been used as a method to detect yeast cells
with active caspases using flow cytometry (Madeo et al.,
2002). As shown in Fig. 1 f, caspase levels are elevated in
strains expressing the 
 
act1
 
-
 
159
 
 mutation, correlating with
increased cell death of this strain. Interestingly however,
the rho
 
 
 
 strain lacking mitochondria, which has restored
viability under these conditions, still has elevated caspase
levels, indicating that high caspase levels alone may not
trigger cell death.
One caveat of such studies is that the presence of a mutant
allele in cells may for a variety of reasons initiate changes
that induce ROS production. To determine whether a re-
duction in actin dynamics in an otherwise wild-type cell also
causes an increase in ROS, we used a yeast strain that is sen-
sitive to the actin stabilizing drug jasplakinolide (KAY339).
Previously we have shown that jasplakinolide addition to
this strain causes a block in actin dynamics and the actin to 
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Figure 1. Actin dynamics correlate with the presence of functional mitochondria and the production of ROS. (a) Comparison of growth on 
agar plates containing glycerol as a carbon source. (b) Presence of mitochondria was determined using a GFP tag fused to a mitochondrial 
targeting sequence. Mitochondrial functionality was assessed using the vital stain DiOC6. DIC image is shown to indicate position of cells. 
Bars, 5  m. (c) FACS
® analysis measured H2O2 levels as an indication of ROS accumulation. The M2 peak represents cells with high levels of 
ROS. (d) Summary graph of the percentage of cells lying in the M2 peak. Errors are standard deviations from three experiments. (e) Rhodamine-
phalloidin staining of actin in act1-159 and act1-159 rho  cells. Corresponding images of DAPI staining show absence of mitochondria in the 
rho  cells. Arrows indicate large chunks of actin, and arrowheads indicate aberrant actin cables. Bar, 5  m. (f) Rhodamine-phalloidin staining 
of actin in wild-type and act1-159 cells. Arrows indicate large chunks of actin. Bar, 5  m. (g) Caspase levels were assayed following incubation 
of cells with the caspase binding molecule FITC-VAD-fmk as described. M2 peak represents the cell population with high levels of caspase. 
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accumulate as a single clump (Ayscough, 2000). To analyze
the effect of jasplakinolide in this study, the drug was added
at low levels overnight to allow concomitant uptake of the
dye used for analysis of ROS production. After this time,
with 0 and 1 
 
 
 
M jasplakinolide addition, actin was still
punctate and polarized, and mitochondrial and nuclear
DNA was normal in appearance. However, 2 
 
 
 
M jasplakin-
olide addition resulted in clumped actin and fragmentation
of nuclear DNA, indicative of apoptosis (Fig. 2 a). In addi-
tion, a dramatic increase in ROS was measured, indicating
that the high ROS levels are a consequence of the changes in
the actin cytoskeleton (Fig. 2 b).
While mutations in actin that increase F-actin stability
and addition of drugs that abrogate actin dynamics both re-
sult in increased ROS and loss of viability, an important
question is whether changes to actin stability may contribute
to aging and cell death in the normal lifespan of yeast. To
address this possibility, we considered proteins that have
been shown to regulate actin dynamics in yeast, in particular
proteins that themselves have been shown to confer stability
on the actin cytoskeleton. These proteins are the tropomyo-
sins 1 and 2 (Tpm1 and Tpm2), the fimbrin homologue
Sac6p (Pruyne and Bretscher, 2000), and most recently de-
scribed, the small actin binding protein Scp1p, which is
related to mammalian SM22/transgelin (Goodman et al.,
2003; Winder et al., 2003). Interestingly, the mammalian
homologue of Scp1p has been identified in replicative senes-
cence screens that demonstrated that aged cells contain
higher levels of the protein than younger cells (Gonos et al.,
1998). Comparison of isogenic strains lacking 
 
tpm1
 
, 
 
sac6
 
,
and 
 
scp1
 
 revealed that all were able to grow on plates con-
taining glycerol as a carbon source, indicating that all con-
tained functional mitochondria (Fig. 3 a). Growth on hy-
drogen peroxide plates showed that wild-type, 
 
 
 
tpm1
 
, and
 
 
 
sac6
 
 cells could grow at 4 mM H
 
2
 
O
 
2
 
; only the 
 
 
 
scp1
 
 strain
was able to grow at 5 mM H
 
2
 
O
 
2
 
 (Fig. 3 a). Finally, compar-
ison of viability demonstrated that after 2 d growth in sta-
tionary phase, 
 
 
 
tpm1
 
 and 
 
 
 
sac6
 
 cells showed reduced viabil-
ity compared with wild-type cells, while the strain lacking
 
scp1
 
 showed increased viability (Fig. 3 b). This result indi-
cates that Sac6p and Tpm1p may have other essential roles
in the cell that cause viability to be affected following their
deletion. Because loss of Scp1p, but not Tpm1p or Sac6p,
Figure 2. Jasplakinolide addition causes actin clumping, nuclear 
fragmentation, and increases the level of ROS in yeast cells. (a) 
KAY339 cells were grown to log phase and half the population was 
then treated with 2  M jasplakinolide overnight. Cells were fixed 
and processed for rhodamine-phalloidin staining to visualize actin, 
and DAPI was added to allow the organization of DNA to be observed. 
Bars, 5  m. (b) Jasplakinolide was added at a range of levels as 
indicated, and cells were incubated overnight in the presence of 
H2-DCFDA for analysis by flow cytometry.
Figure 3. Comparison of strains in which genes 
encoding actin stabilizing proteins tpm1, sac6, and 
scp1 have been deleted. (a) Growth of strains on 
plates containing 3% glycerol as the carbon source, 
or with increasing levels of H2O2. (b) Viability of 
strains after 2 d in stationary phase. Viability was 
assessed as described in the Materials and methods. 
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had an effect on promoting survival on H
 
2
 
O
 
2
 
 and resulted in
increased viability, we chose to investigate the role of this
protein further.
First, levels of ROS were measured in stationary phase
cells over a 16-d time course and were found to be lower in
strains in which 
 
scp1
 
 is deleted, compared with an isogenic
parent strain (Fig. 4 a). To investigate whether this differ-
ence in ROS is linked to aging in yeast, two assays were per-
formed to assess both chronological and replicative aging.
First, cells in which 
 
scp1
 
 is deleted were allowed to grow into
stationary phase, and their viability was assessed over a 15-d
period. Using this approach, we observed a significant in-
crease in viability of 
 
 
 
scp1
 
 cells compared with isogenic
wild-type cells, with 79% ( 3%) of  scp1 cells remaining
viable after 15 d compared with 42% ( 9%) of wild-type
cells (an 88% increase). Second, a replicative aging assay was
performed in which new daughter cells were separated from
their mothers, and the number of new daughter cells that
each of these selected cells was able to generate was recorded
(Lin et al., 2000). This approach showed a very dramatic de-
crease in the aging of cells that carried the scp1 deletion (Fig.
4 b). While the replicative capacity of the wild-type cells av-
erages in the order of 24 generations, those lacking scp1 un-
derwent an average of 40 generations, an increase of 67% in
replicative capacity. This strongly suggests that Scp1p plays
a role in regulating the dynamics of the actin cytoskeleton in
yeast to trigger cell death at an appropriate time, and that
loss of Scp1p results in increased actin dynamics and an in-
crease in longevity.
Having determined that a loss of scp1 can increase viabil-
ity of yeast, we investigated whether the converse were true.
Previously we have shown that overexpression of SCP1 does
indeed cause inviability in yeast (Winder et al., 2003). How-
ever, the mechanism of this was not investigated. As shown
(Fig. 5 a), after 26 h induction, the levels of ROS in cells
were significantly increased in the presence of increased lev-
els of Scp1p. The strains tested contained either an empty
vector (KAY604), a centromeric low copy vector with SCP1
expressed from an inducible promoter (KAY646), or a 2 mi-
cron high copy vector with SCP1 expressed from an induc-
ible promoter (KAY647). The level of ROS correlates with
the level of SCP1 overexpression, indicating that increased
F-actin stability causes ROS accumulation and leads to cell
death. Levels of caspase activation were also determined us-
ing FACS
® analysis in cells overexpressing SCP1, and, as
shown (Fig. 5 b), caspase is elevated in cells with the in-
creased levels of SCP1.
The data we present demonstrate that the actin cytoskele-
ton can play a central role in regulating apoptosis in yeast.
Furthermore, it appears likely that this pathway may be part
of a cell aging process in yeast and potentially in mammalian
cells. As such, it identifies a further role for the actin cyto-
skeleton in eukaryotes and reiterates the critical role that ac-
tin plays in fundamental cell processes. In yeast, a tight cou-
pling of the mitochondria to the cytoplasmic actin cables has
been recognized for many years (Read et al., 1992; Simon et
al., 1997). In addition, several proteins, including Mmm1p
and Mdm10p, have been identified that directly couple mi-
Figure 4. The effect of SCP1 deletion on ROS 
production and aging. (a) Flow cytometry was 
undertaken to measure H2O2 levels as an indica-
tion of ROS accumulation in wild-type (KAY446) 
and  scp1 (KAY448) cells. Depicted here is the 
percentage of cells at each time point with high 
levels of ROS. (b) A replicative aging assay was 
performed in wild-type and  scp1 cells. In each 
assay, 32 cells were studied, and each daughter 
cell produced by a mother cell was counted.
Figure 5. Overexpression of SCP1 
induces production of ROS and yeast 
caspase. Cells expressing wild-type levels 
of Scp1p, or carrying SCP1 on a centro-
meric plasmid or on a high copy plasmid 
were shifted to medium to induce ex-
pression of SCP1 from the methionine 
promoter. U, uninduced; I, induced SCP1 
expression after 26 h induction. (a) ROS 
levels were measured as described in the 
Materials and methods. Shown here is 
the percentage of cells with high ROS 
levels. (b) Caspase levels were assayed 
by flow cytometry following incubation 
of cells with the caspase inhibitor FITC-
VAD-fmk. Error bars shown are the SEM.808 The Journal of Cell Biology | Volume 164, Number 6, 2004
tochondria to the actin cytoskeleton (Boldogh et al., 1998).
However, until now, this link has been proposed to be in-
volved in maintaining mitochondrial morphology and en-
suring movement of mitochondria in to the newly growing
daughter cell. The work we present suggests that the actin
mitochondrial association may also serve to regulate mi-
tochondrial depolarization and subsequent production of
ROS. One possible mechanism for coupling is that actin
may associate with channels in the mitochondrial membrane
to regulate opening or closing. Slowing of actin dynamics
might lead to the pores or channels being opened for a pro-
longed time, thus reducing membrane potential and increas-
ing release of ROS into the cytoplasm. Conversely enhanced
dynamics may reduce opening times, reducing release of
damaging ROS and promoting lifespan of the organism. Ev-
idence for this model is reported from other studies. The
mammalian actin binding protein gelsolin has been shown
to regulate closure of the mitochondrial voltage dependent
anion channel (VDAC), and this function also correlates
with induction of apoptotic changes (Kusano et al., 2000).
Furthermore, actin has been shown to modulate gating of
VDAC in a Neurospora crassa in vitro system (Xu et al.,
2001). In agreement with our results, data from this study
demonstrated that stabilization of F-actin blocked the ability
to modulate opening of the channel.
In summary, we have demonstrated the importance of ac-
tin cytoskeleton dynamics in regulating the production of
ROS in yeast and have determined that coupling of actin
and the mitochondria is central to this mechanism. Impor-
tantly, we also show that deletion of the SCP1 gene encod-
ing an actin bundling protein significantly increases the
lifespan of yeast, indicating that this pathway is also part of a
pathway regulating aging processes.
Materials and methods
Strains, plasmids, and growth of yeast
Yeast strains used were KAY159 (MATa ura3-52, leu2-3,112, cry1, tub2-
201, ACT1::HIS3, his3 200); KAY375 (MATa ura3-52, leu2-3,112, ade4,
ade2,  tub2-201,  act1-159::HIS3,  his3 200); KAY603 (MATa  ura3-52,
leu2-3,112,  ade2-101,  tub2-201,  act1-159::HIS3,  his3 200,  can1 );
KAY339 (MATa  ste6::hisG,  pdr5::TRP1, snq2::hisG,  erg6::LEU2, ura3-
52, his3- 200 leu2- 1, trp1- 63, lys2-801 ade2-101); KAY446 (MATa,
his3 ,  leu2 ,  met15 ,  ura3 ); KAY448 (KAY446
    scp1::KanMx);
KAY593 (KAY446
    sac6::KanMx); and KAY679 (KAY446
    tpm1::
KanMx). KAY446 was transformed with pKA256 (empty vector), pKA280
(CEN, pMET-SCP1), or pKA281 (2  pMET-SCP1) to generate strains
KAY604, KAY646, and KAY647, respectively. Plasmids are described else-
where (Winder et al., 2003).
Yeast were grown with shaking at 30 C in liquid YPD (1% yeast extract,
2% peptone, 2% glucose) or synthetic medium (lacking uracil; Sigma-
Aldrich). Solid media was made by addition of 2% agar. For glycerol
plates, the glucose was replaced with 3% glycerol. Overexpression of
SCP1 was induced by switching cells onto media lacking methionine
(Winder et al., 2003). The rho  strain of KAY375 was made as previously
described (Guthrie and Fink, 1991). Jasplakinolide was added to amounts
indicated from a 5 mM stock in DMSO.
Fluorescence procedures
Rhodamine-phalloidin and DAPI staining was performed as previously de-
scribed (Hagan and Ayscough, 2000). Staining of mitochondria with
DiOC6 was performed as published (Pringle et al., 1989). Visualization of
mitochondria using GFP on a mitochondrial localization peptide was
achieved by transformation of cells with PVTU100U-mtGFP (Westermann
and Neupert, 2000). Cell images were recorded from a BX60 Olympus mi-
croscope with a Roper Scientific Micromax camera and captured on a
Macintosh 7300 computer. Images were processed using Adobe Photo-
shop 7.0
® software.
ROS production.  Cells were incubated overnight in the presence of 5
 g/ml 2’,7’-dichloro dihydrofluorescein diacetate (H2-DCFDA; Molecular
Probes). Cells were sonicated and analyzed using a Becton Dickinson flow
cytometer. Parameters were set at excitation and emission settings of 304
and 551 nm (filter FL-1), respectively. For each experiment, two peaks of
fluorescence were observed. The second peak represents cells with high
levels of ROS. Experiments were repeated at least three times indepen-
dently. Representative datasets are depicted. Errors shown are standard de-
viations. In vivo caspase levels were measured as previously described
(Madeo et al., 2002) using a staining solution containing FITC-VAD-fmk
(CaspACE™; Promega).
Aging assays
Chronological aging assay.  Cells were grown in YPD medium on a shaker
with high aeration (220 rpm) at 30 C. Samples were sonicated before cell
number determination, in triplicate, with a Schärfe Systems TT cell
counter. Serial dilutions were plated on YPD plates, and numbers of grow-
ing colonies were counted in triplicate platings.
Reproductive capacity was assessed using the methods previously de-
scribed (Lin et al., 2000). In brief, cells from log phase cultures were plated
at low density. Daughter cells were isolated as buds that emerged from
mother cells and removed using a Singer Instruments MSM manual micro-
manipulator. Life span was determined by removing all subsequent daugh-
ter cells generated. The average reproductive lifespan was calculated from
the dissection of budding cells from 32 starting cells for each strain tested.
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